Up Next
0
Dendreon Down, Ctrip.com Up
CNBC's Brian Sullivan & Amanda Drury share their gloomy and sunny stock picks, including Dendreon down 81% in the last year amid lawsuits over its cancer drug, Provenge.
Share
Dendreon Down, Ctrip.com Up
CNBC's Brian Sullivan & Amanda Drury share their gloomy and sunny stock picks, including Dendreon down 81% in the last year amid lawsuits over its cancer drug, Provenge.
Date: 5/17/12
Views: 133
Video by:  CNBC
 
Follow us:
Loading... 1 of 167
Today's Most Watched Videos
Related Videos
Loading... 1 of 56